Vanguard Group Inc Curis Inc Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.57 - $0.99 $188,347 - $327,129	330,434 Added 10.78%	3,395,046 $2.82 Million
Q4 2022 Feb 10, 2023	BUY	$0.47 - $17.22 $316,709 - $11.6 Million	673,850 Added 28.19%	3,064,612 $1.69 Million
Q3 2022 Nov 14, 2022	SELL	$0.74 - $15.01 $1.02 Million - $20.7 Million	-1,380,688 Reduced 36.61%	2,390,762 $1.67 Million
Q2 2022 Aug 12, 2022	SELL	$0.71 - $2.43 $333,812 - $1.14 Million	-470,158 Reduced 11.08%	3,771,450 $3.71 Million
Q1 2022 May 13, 2022	BUY	$2.31 - $5.13 $90,043 - $199,967	38,980 Added 0.93%	4,241,608 $10.1 Million
Q4 2021 Feb 14, 2022	BUY	$4.45 - $8.09 $155,198 - $282,146	34,876 Added 0.84%	4,202,628 $20 Million
Q3 2021 Nov 12, 2021	SELL	$6.94 - $8.85 $381,283 - $486,219	-54,940 Reduced 1.3%	4,167,752 $32.6 Million
Q2 2021 Aug 13, 2021	BUY	$7.45 - $16.27 $31.5 Million - $68.7 Million	4,222,692 New	4,222,692 $34.1 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.